Predict your next investment

Corporation
HEALTHCARE | Biotechnology
hgsi.com

See what CB Insights has to offer

Founded Year

1992

Stage

Acq - P2P | Acquired

Valuation

$0000 

Revenue

$0000 

About Human Genome Sciences

Human Genome Sciences is a development stage company that was formed to develop and commercialize therapeutically enhanced proprietary biopharmaceuticals with the aim of offering significant reductions in dosage, injection frequency, side effects, and overall cost of treatment.In July 2012, Human Genome Sciences was acquired by GlaxoSmithKline. The valuation of Human Genome Sciences was $3.6 billion.

Human Genome Sciences Headquarter Location

14200 Shady Grove Road

Rockville, Maryland, 20850,

United States

Latest Human Genome Sciences News

05.15.12 GSK Offers $2.6B For Human Genome Sciences

Jun 18, 2018

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio . All rights reserved. All other trademarks recognized. Copyright © 1997-2018 BioPortfolio Limited. Site developed by Alacrify Ltd .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Human Genome Sciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Human Genome Sciences is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Human Genome Sciences Patents

Human Genome Sciences has filed 135 patents.

The 3 most popular patent topics include:

  • Audio equipment manufacturers
  • Audio engineering
  • Headphones manufacturers
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/3/2019

3/9/2021

Headphones manufacturers, Audio equipment manufacturers, Hearing, DOS games, Radio electronics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/3/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/9/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Headphones manufacturers, Audio equipment manufacturers, Hearing, DOS games, Radio electronics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.